ArticleNature communications2013
SMRT compounds abrogate cellular phenotypes of ataxia telangiectasia in neural derivatives of patient-specific hiPSCs.
Peiyee Lee et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
21 papers cite it
this papercites it